The global biologics contract manufacturing market is undergoing significant expansion as pharmaceutical and biotechnology companies increasingly outsource development and manufacturing activities to specialized contract manufacturing organizations (CMOs). Growing biologics pipelines, rising demand for monoclonal antibodies and recombinant proteins, and the increasing complexity of biologic...
